2021 ADEA-NSW/ACT Branch Conference

 

NSW/ACT Branch Conference 2021 Registration
Program
Speakers
Sponsors
Venue

Program

Saturday 27 March 2021
8.30am Registration
9.00am Welcome and Housekeeping
9.05am Bariatric Surgery – Dr. Nic Kormas, Senior Staff Specialist Endocrinology at Camden, Campbelltown and Concord Repatriation General Hospitals

In trials, bariatric surgery is the most efficacious treatment for weight loss and management of diabetes in adults with clinically severe obesity. In the real world however, up to 20% of patients having bariatric surgery may not have a good outcome. This mainly occurs as a result of less than expected weight loss rather than a complication from the surgery.
In today’s presentation I will describe where bariatric surgery fits in the management of people with obesity and diabetes. Not all patients who have a BMI > 35kg/m2 with diabetes and suboptimal glycaemic control are suitable for bariatric surgery. I will detail how to select and prepare patients for bariatric surgery, as well as give recommendations for how and how long they should be followed up.

9.55am Update on the Gestational Diabetes Position Statement – Ms. Amanda Bartlett, CDE and midwife

This presentation will provide an update on the Joint Position Statement on Gestational Diabetes in Australia released by Diabetes Australia, the Australian Diabetes Educators Association and the Australian Diabetes Society in August 2020.  The Statement sets out the scale of the problem, the challenges, and a range of new approaches needed.

11.00am New Medications – Associate Professor Roger Chen, Senior Staff Specialist, Diabetes and Endocrinology, St. Vincent’s Hospital Sydney

The past few years have seen the availability of a number of “ new” medications for Type 2 diabetes.  These include the SGLT 2 inhibitors of which there are three available on the PBS in Australia, the GLP-1 Receptor Agonists of which there are now four on the PBS and one on private prescription.    Both of these classes of agents also have a growing number of cardiovascular safety studies which show positive but variable effects on cardiovascular and renal disease, which are likely modulated through non glycaemic mechanisms.  These medications also other benefits such as weight loss, decreases in blood pressure and low rates of hypoglycaemia unless combined with insulin or sulphonylureas.  In this talk, the mechanisms by which these medications work will be outlined together with results of these cardiovascular outcome studies and the role of these medications will be discussed.  It is particularly intriguing that benefits have been seen with these agents (SGLT 2 inhibitors) in populations without diabetes, such as those with cardiac failure and renal disease. In addition, newer agents such as once weekly insulins (Icodec) and GLP-1 RA/ GIP dual agonists (Tirzepatide) are also looking promising.

11.50am NDSS Update

Vania Khoury, National CALD Priority Lead, Diabetes Australia

12.00pm Sponsor and delegate interaction
12.30pm LUNCH
1.15pm CGM and Pumps – Ms. Marlene Payk, Nurse Practitioner – diabetes, PD, MNP, BN, RNCDE

This session will focus on the current Continuous Glucose Monitoring (CGM) and Insulin Pump Therapy (IPT) systems available in Australia for diabetes self-management. Case based studies and experiences of people with diabetes will be included.

2.05pm Using Telehealth – Ms. Ann Bush, RN CDE

Utilising telehealth became a necessity in 2020 when it became difficult to conduct face to face consultations. Whilst we all had to make some quick adjustments to the way we practice not everyone feels comfortable embracing telehealth. This presentation is a practical look at establishing a telehealth clinic – platforms available, ensuring compliance with privacy and data security and avoiding potential issues. I will be speaking about my experience, discussing some of my cases that worked well and some that did not, as well as drawing on some of the evidence coming through regarding the benefits of telehealth.

3.00pm Branch Meeting – agenda available here
3.30pm Close

Speakers

Amanda Bartlett Amanda is a midwife of over 30 years’ experience and a credentialled diabetes educator. She currently works two days a week as a midwife in private practice with two leading Sydney obstetricians and runs her own private practice in diabetes education in Sydney which has been established for over 10 years. She specialises in T1DM, diabetes during pregnancy, insulin pump training and stabilisation and continuous glucose monitoring. She is a guest lecturer at UTS and the current vice president of ADEA.
Ann Bush Ann has been a Registered Nurse for just over 30 years, for 27 of those she has been working as a Diabetes Educator. She has had experience in metropolitan hospitals, rural community health and for the past 8 years in private practice. Ann has also worked as a course advisor, moderator and sessional lecturer in the post Grad Cert of Diabetes Health and Education and is also currently working as an Agent on the Sanofi Simple Steps Diabetes assistance line.  Ann is a current Board member of ADEA and sits on expert advisory panels. In the past she has been a member of the Vic Branch Executive, has been on several conference organising committees and in recent times much to her surprise has become a bit of an expert in Telehealth.
Associate Professor Roger Chen Associate Professor Chen is Senior Staff Specialist, Diabetes and Endocrinology at St Vincent’s Hospital, Sydney with clinical interests in general endocrinology, diabetes and osteoporosis. He is visiting specialist, Diabetes and Metabolism at the Garvan Institute of Medical Research. He is also Clinical Associate Professor in Medicine at the University of Sydney and Conjoint Associate Professor at UNSW.
Marlene Payk Marlene Payk (Nurse Practitioner – Diabetes, PD, MNP, BN, RNCDE) is an experienced Nurse Practitioner working in both public and private practice. She has been working as a diabetes educator for over 25years and works with people with all types of diabetes. Marlene has completed a Professional Doctorate of Nurse Practitioner and her research focused on type 1 diabetes and insulin pump therapy. Marlene’s interest sinclude the use of technology to assist with diabetes self-management. Marlene is an active member of the Australian Diabetes Educators Association (ADEA), mentoring new members embarking on obtaining their initial credentialing and she is current secretary of the NSW ADEA Branch and has previously held the position of NSW ADEA Branch chair.
Nic Kormas Dr Nic Kormas is a Senior Staff Specialist Endocrinologist & Obesity Physician. He initiated and is the Clinical Lead of The Metabolic Rehabilitation Programs at Concord Repatriation General Hospital (2003), The South Western Sydney Metabolic Rehabilitation & Bariatric Program at Camden Hospital (2009) & The Tharawal Aboriginal Community Controlled Health Service Obesity Diseases Clinic (2021). These programs are intensive interdisciplinary programs, managing adults with severe obesity and obesity related diseases. He is the Coordinator of the Sydney Local Hospital District Publically Funded Bariatric Surgery Program; the largest program in NSW, from its initiation in 2009 to date. Dr Kormas is also the Treasurer for The National Association of Clinical Obesity Services and the clinician Board Member for The Weight Issues Network.

Sponsors


Gold

Silver

Bronze

Venue

This conference is being held online.

2021 ADEA-NSW/ACT Branch Conference

 

NSW/ACT Branch Conference 2021 Registration
Program
Speakers
Sponsors
Venue

Program

Saturday 27 March 2021
8.30am Registration
9.00am Welcome and Housekeeping
9.05am Bariatric Surgery – Dr. Nic Kormas, Senior Staff Specialist Endocrinology at Camden, Campbelltown and Concord Repatriation General Hospitals

In trials, bariatric surgery is the most efficacious treatment for weight loss and management of diabetes in adults with clinically severe obesity. In the real world however, up to 20% of patients having bariatric surgery may not have a good outcome. This mainly occurs as a result of less than expected weight loss rather than a complication from the surgery.
In today’s presentation I will describe where bariatric surgery fits in the management of people with obesity and diabetes. Not all patients who have a BMI > 35kg/m2 with diabetes and suboptimal glycaemic control are suitable for bariatric surgery. I will detail how to select and prepare patients for bariatric surgery, as well as give recommendations for how and how long they should be followed up.

9.55am Update on the Gestational Diabetes Position Statement – Ms. Amanda Bartlett, CDE and midwife

This presentation will provide an update on the Joint Position Statement on Gestational Diabetes in Australia released by Diabetes Australia, the Australian Diabetes Educators Association and the Australian Diabetes Society in August 2020.  The Statement sets out the scale of the problem, the challenges, and a range of new approaches needed.

11.00am New Medications – Associate Professor Roger Chen, Senior Staff Specialist, Diabetes and Endocrinology, St. Vincent’s Hospital Sydney

The past few years have seen the availability of a number of “ new” medications for Type 2 diabetes.  These include the SGLT 2 inhibitors of which there are three available on the PBS in Australia, the GLP-1 Receptor Agonists of which there are now four on the PBS and one on private prescription.    Both of these classes of agents also have a growing number of cardiovascular safety studies which show positive but variable effects on cardiovascular and renal disease, which are likely modulated through non glycaemic mechanisms.  These medications also other benefits such as weight loss, decreases in blood pressure and low rates of hypoglycaemia unless combined with insulin or sulphonylureas.  In this talk, the mechanisms by which these medications work will be outlined together with results of these cardiovascular outcome studies and the role of these medications will be discussed.  It is particularly intriguing that benefits have been seen with these agents (SGLT 2 inhibitors) in populations without diabetes, such as those with cardiac failure and renal disease. In addition, newer agents such as once weekly insulins (Icodec) and GLP-1 RA/ GIP dual agonists (Tirzepatide) are also looking promising.

11.50am NDSS Update

Vania Khoury, National CALD Priority Lead, Diabetes Australia

12.00pm Sponsor and delegate interaction
12.30pm LUNCH
1.15pm CGM and Pumps – Ms. Marlene Payk, Nurse Practitioner – diabetes, PD, MNP, BN, RNCDE

This session will focus on the current Continuous Glucose Monitoring (CGM) and Insulin Pump Therapy (IPT) systems available in Australia for diabetes self-management. Case based studies and experiences of people with diabetes will be included.

2.05pm Using Telehealth – Ms. Ann Bush, RN CDE

Utilising telehealth became a necessity in 2020 when it became difficult to conduct face to face consultations. Whilst we all had to make some quick adjustments to the way we practice not everyone feels comfortable embracing telehealth. This presentation is a practical look at establishing a telehealth clinic – platforms available, ensuring compliance with privacy and data security and avoiding potential issues. I will be speaking about my experience, discussing some of my cases that worked well and some that did not, as well as drawing on some of the evidence coming through regarding the benefits of telehealth.

3.00pm Branch Meeting – agenda available here
3.30pm Close

Speakers

Amanda Bartlett Amanda is a midwife of over 30 years’ experience and a credentialled diabetes educator. She currently works two days a week as a midwife in private practice with two leading Sydney obstetricians and runs her own private practice in diabetes education in Sydney which has been established for over 10 years. She specialises in T1DM, diabetes during pregnancy, insulin pump training and stabilisation and continuous glucose monitoring. She is a guest lecturer at UTS and the current vice president of ADEA.
Ann Bush Ann has been a Registered Nurse for just over 30 years, for 27 of those she has been working as a Diabetes Educator. She has had experience in metropolitan hospitals, rural community health and for the past 8 years in private practice. Ann has also worked as a course advisor, moderator and sessional lecturer in the post Grad Cert of Diabetes Health and Education and is also currently working as an Agent on the Sanofi Simple Steps Diabetes assistance line.  Ann is a current Board member of ADEA and sits on expert advisory panels. In the past she has been a member of the Vic Branch Executive, has been on several conference organising committees and in recent times much to her surprise has become a bit of an expert in Telehealth.
Associate Professor Roger Chen Associate Professor Chen is Senior Staff Specialist, Diabetes and Endocrinology at St Vincent’s Hospital, Sydney with clinical interests in general endocrinology, diabetes and osteoporosis. He is visiting specialist, Diabetes and Metabolism at the Garvan Institute of Medical Research. He is also Clinical Associate Professor in Medicine at the University of Sydney and Conjoint Associate Professor at UNSW.
Marlene Payk Marlene Payk (Nurse Practitioner – Diabetes, PD, MNP, BN, RNCDE) is an experienced Nurse Practitioner working in both public and private practice. She has been working as a diabetes educator for over 25years and works with people with all types of diabetes. Marlene has completed a Professional Doctorate of Nurse Practitioner and her research focused on type 1 diabetes and insulin pump therapy. Marlene’s interest sinclude the use of technology to assist with diabetes self-management. Marlene is an active member of the Australian Diabetes Educators Association (ADEA), mentoring new members embarking on obtaining their initial credentialing and she is current secretary of the NSW ADEA Branch and has previously held the position of NSW ADEA Branch chair.
Nic Kormas Dr Nic Kormas is a Senior Staff Specialist Endocrinologist & Obesity Physician. He initiated and is the Clinical Lead of The Metabolic Rehabilitation Programs at Concord Repatriation General Hospital (2003), The South Western Sydney Metabolic Rehabilitation & Bariatric Program at Camden Hospital (2009) & The Tharawal Aboriginal Community Controlled Health Service Obesity Diseases Clinic (2021). These programs are intensive interdisciplinary programs, managing adults with severe obesity and obesity related diseases. He is the Coordinator of the Sydney Local Hospital District Publically Funded Bariatric Surgery Program; the largest program in NSW, from its initiation in 2009 to date. Dr Kormas is also the Treasurer for The National Association of Clinical Obesity Services and the clinician Board Member for The Weight Issues Network.

Sponsors


Gold

Silver

Bronze

Venue

This conference is being held online.